Nemaura Medical Financials

Nemaura Medical Stock Summary

Nemaura Medical competes with Neuropace, CVRx, Orthofix Medical, Artivion, and Bluejay Diagnostics. Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. Nemaura Med operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 32 people.

Nemaura Medical Key Financial Ratios

There are many critical financial ratios that Nemaura Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Nemaura Medical reports annually and quarterly.

Nemaura Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nemaura Medical's current stock value. Our valuation model uses many indicators to compare Nemaura Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nemaura Medical competition to find correlations between indicators driving Nemaura Medical's intrinsic value. More Info.Nemaura Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nemaura Medical's earnings, one of the primary drivers of an investment's value.

Nemaura Medical Market Pulse

Along with financial statement analysis, the daily predictive indicators of Nemaura Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nemaura Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nemaura Medical based on widely used predictive technical indicators. In general, we focus on analyzing Nemaura Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nemaura Medical's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.